Genetic collagen diseases: Influence of collagen mutations on structure and mechanical behavior

Collagen: Structure and Mechanics

Volumn , Issue , 2008, Pages 447-474

  Blank, R D ^a   Boskey, A L ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952362145     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-73906-9_16     Document Type: Chapter

References (178)

1. Aubin I, Adams CP, Opsahl S, Septier D, Bishop CE, Auge N, Salvayre R, Negre-Salvayre A, Goldberg M, Guenet JL, Poirier C (2005) A deletion in the gene encoding sphingomyelin phos-phodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet. 37:803-805.
2. Bachinger HP, Morris NP, Davis JM (1993) Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the triple helix of type I collagen. Am J Med Genet. 45:152-162.
3. Balemans W, Van Hul W (2007) The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology.148:2622- 2629.
4. Balk ML, Bray J, Day C, Epperly M, Greenberger J, Evans CH, Niyibizi C (1997) Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim). Bone. 21:7-15.
5. Bard JB, Kratochwil K (1987) Corneal morphogenesis in the Mov13 mutant mouse is characterized by normal cellular organization but disordered and thin collagen. Development. 101:547-555.
6. Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC (2006) Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med. 355:2757-2764.
7. Bateman JF, Mascara T, Cole WG, Stacey A, Jaenisch R (1989) Collagen protein abnormalities produced by site-directed mutagenesis of the pro alpha 1(I) gene. Connect Tissue Res. 20: 205-212.
8. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997.
9. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet.77:31-37.
10. Bodine PV, Komm BS (2006) Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord. 7:33-39.
11. Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Wiman J, Brinkley L, Dolan DF, Altschuler RA, Hawkins JE, Bateman JF, Mascara T, Jaenisch R (1990) Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA.87: 7145-7149.
12. Bonadio J, Jepsen KJ, Mansoura MK, Jaenisch R, Kuhn JL, Goldstein SA (1993) A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility. J Clin Invest. 92:1697-1705.
13. Breindl M, Harbers K, Jaenisch R (1984) Retrovirus-induced lethal mutation in collagen I gene of mice is associated with an altered chromatin structure. Cell. 38:9-16.
14. Brenner RE, Vetter U, Stoss H, Muller PK, Teller WM (1993) Defective collagen fibril formation and mineralization in osteogenesis imperfecta with congenital joint contractures (Bruck syndrome). Eur J Pediatr. 152:505-508.
15. Bristow J, Carey W, Egging D, Schalkwijk J (2005) Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 139:24-30.
16. Byers PH (1993) Osteogenesis Imperfecta in Royce PM and Steinmann B (eds) Connective Tissues and Its Heritable Disorders, Wiley Liss, New York, pp 317-350.
17. Byers PH, Wallis GA, Willing MC (1991) Osteogenesis imperfecta: translation of mutation to phenotype. J Med Genet. 28:433-442.
18. Byers PH, Duvic M, Atkinson M, Robinow M, Smith LT, Krane SM, Greally MT, Ludman M, Matalon R, Pauker S, Quanbeck D, Schwarze U (1997) Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet. 72:94-105.
19. Cabral WA, Makareeva E, Colige A, Letocha AD, Ty JM, Yeowell HN, Pals G, Leikin S, Marini JC (2005) Mutations near amino end of alpha1(I) collagen cause combined osteoge-nesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing. J Biol Chem. 280:19259-19269.
20. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat Genet. 39:359-365.
21. Camacho NP, Hou L, Toledano TR, Ilg WA, Brayton CF, Raggio CL, Root L, Boskey AL (1999) The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res. 14:264-272.
22. Camacho NP, Raggio CL, Doty SB, Root L, Zraick V, Ilg WA, Toledano TR, Boskey AL (2001) A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif Tissue Int. 69:94-101.
23. Campbell BG, Wootton JA, Krook L, DeMarco J, Minor RR (1997) Clinical signs and diagnosis of osteogenesis imperfecta in three dogs. J Am Vet Med Assoc. 211:183-187.
24. Cassella JP, Barber P, Catterall AC, Ali SY (1994) A morphometric analysis of osteoid collagen fibril diameter in osteogenesis imperfecta. Bone.15:329-334.
25. Cheung MS, Glorieux FH, Rauch F (2007) Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res. 22:1181-1186.
26. Chiodo AA, Hockey A, Cole WG (1992) A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII. J Biol Chem. 267:6361-6369.
27. Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr, Shuldiner AR, Wenstrup RJ, Rowe DW, Shapiro JR (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA. 90: 1701-1705.
28. Cohen-Solal L, Zolezzi F, Pignatti PF, Mottes M (1996) Intrafamilial variable expressivity of osteo-genesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene. Mol Cell Probes. 10:219-225.
29. Cohn LA, Meuten DJ (1990) Bone fragility in a kitten: an osteogenesis imperfecta-like syndrome. J Am Vet Med Assoc. 197:98-100.
30. Cole WG, Chan D, Chambers GW, Walker ID, Bateman JF (1986) Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem. 261:5496-5503.
31. Constantinou CD, Pack M, Young SB, Prockop DJ (1990) Phenotypic heterogeneity in osteoge-nesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1). Am J Hum Genet. 47:670-679.
32. Constantinou-Deltas CD, Ladda RL, Prockop DJ (1993) Somatic cell mosaicism: another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfecta. Am J Med Genet 45:246-251.
33. Czarny-Ratajczak M, Lohiniva J, Rogala P, Kozlowski K, Perala M, Carter L, Spector TD, Kolodziej L, Seppanen U, Glazar R, Krolewski J, Latos-Bielenska A, Ala-Kokko L (2001) A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. Am J Hum Genet. 69:969-980.
34. D'Alessio M, Ramirez F, Blumberg BD, Wirtz MK, Rao VH, Godfrey MD, Hollister DW (1991) Characterization of a COL1A1 splicing defect in a case of Ehlers-Danlos syndrome type VII: further evidence of molecular homogeneity. Am J Hum Genet 49:400-406.
35. Dalgleish R (1997) The human type I collagen mutation database. Nucleic Acids Res. 25:181-187.
36. Dalgleish R (1998) The human collagen mutation database 1998. Nucleic Acids Res. 26:253-255.
37. Dawson PA, Kelly TE, Marini JC (1999) Extension of phenotype associated with structural mutations in type I collagen: siblings with juvenile osteoporosis have an alpha2(I)Gly436-→ Arg substitution. J Bone Miner Res. 14:449-455.
38. Deak SB, Nicholls A, Pope FM, Prockop DJ (1983). The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen. J Biol Chem. 258:15192-15197.
39. De Paepe A, Nuytinck L, Raes M, Fryns JP (1997) Homozygosity by descent for a COL1A2 mutation in two sibs with severe osteogenesis imperfecta and mild clinical expression in the heterozygotes. Hum Genet 99:478-483.
40. Di Lullo GA, Sweeney SM, Korkko J, Ala-Kokko L, San Antonio JD (2002) Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem. 277:4223-4231.
41. Edwards MJ, Wenstrup RJ, Byers PH, Cohn DH (1992) Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease. Hum Mutat. 1:47-54.
42. Ee HL, Liu L, Goh CL, McGrath JA (2007) Clinical and molecular dilemmas in the diagnosis of familial epidermolysis bullosa pruriginosa. J Am Acad Dermatol. 56:S77-81.
43. Evans KD, Lau ST, Oberbauer AM, Martin RB (2003) Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta. Bone. 32: 268-274.
44. Evason MD, Taylor SM, Bebchuk TN (2007) Suspect osteogenesis imperfecta in a male kitten. Can Vet J. 48:296-298.
45. Eyre DR, Shapiro FD, Aldridge JF (1985) A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain. J Biol Chem. 260:11322-11329.
46. Feshchenko S, Brinckmann J, Lehmann HW, Koch HG, Muller PK, Kugler S (1998) Identification of a new heterozygous point mutation in the COL1A2 gene leading to skipping of exon 9 in a patient with joint laxity, hyperextensibility of skin and blue sclerae. Mutations in brief no. 166. Online. Hum Mutat. 12:138.
47. Fichard A, Chanut-Delalande H, Ruggiero F (2003) [The Ehlers-Danlos syndrome: the extracellular matrix scaffold in question] Med Sci (Paris). 19:443-452.
48. Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC (1999) Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J Biol Chem. 274:37923-37931.
49. Forlino A, Tani C, Rossi A, Lupi A, Campari E, Gualeni B, Bianchi L, Armini A, Cetta G, Bini L, Marini JC (2007) Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta. Proteomics. 7:1877-1891.
50. Francis MJ, Williams KJ, Sykes BC, Smith R (1981) The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta. Clin Sci (Lond). 60:617-623.
51. Gensure RC, Makitie O, Barclay C, Chan C, Depalma SR, Bastepe M, Abuzahra H, Couper R, Mundlos S, Sillence D, Ala Kokko L, Seidman JG, Cole WG, Juppner H (2005) A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J Clin Invest. 115:1250-1257.
52. Giunta C, Superti-Furga A, Spranger S, Cole WG, Steinmann B (1999) Ehlers-Danlos syndrome type VII: clinical features and molecular defects. J Bone Joint Surg Am. 81: 225-238.
53. Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ (2000) Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 15:1650-1658.
54. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 17: 30-38.
55. Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard MJ, Olsen BR, Warman ML (1996). Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet. 59:146-151.
56. Grabner B, Landis WJ, Roschger P, Rinnerthaler S, Peterlik H, Klaushofer K, Fratzl P (2001) Age-and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone. 29:453-457.
57. Harbers K, Kuehn M, Delius H, Jaenisch R (1984) Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice. Proc Natl Acad Sci USA 81:1504-1508.
58. Hartung S, Jaenisch R, Breindl M (1986) Retrovirus insertion inactivates mouse alpha 1(I) collagen gene by blocking initiation of transcription. Nature. 320:365-367.
59. Hata R, Kurata S, Shinkai H (1988) Existence of malfunctioning pro alpha2(I) collagen genes in a patient with a pro alpha 2(I)-chain-defective variant of Ehlers-Danlos syndrome. Eur J Biochem. 174:231-237.
60. Ha-Vinh R, Alanay Y, Bank RA, Campos-Xavier AB, Zankl A, Superti-Furga A, Bonafe L (2004) Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am J Med Genet A.131:115-120.
61. Ho KK, Kong RY, Kuffner T, Hsu LH, Ma L, Cheah KS (1994) Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII. Hum Mutat. 3:358-364.
62. Hermanns-Le T, Pierard GE (2006) Collagen fibril arabesques in connective tissue disorders. Am J Clin Dermatol. 7:323-326.
63. Houdebine LM (2002) The methods to generate transgenic animals and to control transgene expression. J Biotechnol. 98:145-160.
64. Hyde TJ, Bryan MA, Brodsky B, Baum J (2006) Sequence dependence of renucleation after a Gly mutation in model collagen peptides. J Biol Chem. 281:36937-36943.
65. Jaenisch R, Harbers K, Schnieke A, Lohler J, Chumakov I, Jahner D, Grotkopp D, Hoffmann E (1983) Germline integration of moloney murine leukemia virus at the Mov13 locus leads to recessive lethal mutation and early embryonic death. Cell. 32:209-216.
66. Jahner D, Jaenisch R (1985) Retrovirus-induced de novo methylation of flanking host sequences correlates with gene inactivity. Nature. 315:594-597.
67. Jenkins CL, Bretscher LE, Guzei IA, Raines RT (2003) Effect of 3-hydroxyproline residues on collagen stability. J Am Chem Soc. 125:6422-6427.
68. Jensen PT, Rasmussen PG, Basse A (1976) Congenital osteogenesis imperfecta in Charollais cattle. Nord Vet Med. 28:304-308.
69. Jepsen KJ, Goldstein SA, Kuhn JL, Schaffler MB, Bonadio J (1996). Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res. 14:493-499.
70. Jepsen KJ, Schaffler MB, Kuhn JL, Goulet RW, Bonadio J, Goldstein SA (1997). Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue. J Biomech. 30: 1141-1147.
71. Kamoun-Goldrat AS, Le Merrer MF (2007) Animal models of osteogenesis imperfecta and related syndromes. J Bone Miner Metab. 25:211-218.
72. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 157:303-314.
73. Kefalides NA (1973) Structure and biosynthesis of basement membranes. Int Rev Connect Tissue Res. 6:63-104.
74. Khillan JS, Olsen AS, Kontusaari S, Sokolov B, Prockop DJ (1991) Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta. J Biol Chem. 266:23373-23379.
75. King D, Chase J, Havey RM, Voronov L, Sartori M, McEwen HA, Beamer WG, Patwardhan AG (2005a) Effects of growth hormone transgene expression on vertebrae in a mouse model of osteogenesis imperfecta. Spine. 30:1491-1495.
76. King D, Jarjoura D, McEwen HA, Askew MJ (2005b) Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta. J Bone Miner Res. 20:987-993.
77. Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA (2004) Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res. 19:614-622.
78. Kratochwil K, Dziadek M, Lohler J, Harbers K, Jaenisch R (1986) Normal epithelial branching morphogenesis in the absence of collagen I. Dev Biol. 117:596-606.
79. Kratochwil K, von der Mark K, Kollar EJ, Jaenisch R, Mooslehner K, Schwarz M, Haase K, Gmachl I, Harbers K (1989) Retrovirus-induced insertional mutation in Mov13 mice affects collagen I expression in a tissue-specific manner. Cell. 57:807-816.
80. Kuivaniemi H, Tromp G, Prockop DJ (1997) Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat. 9:300-315.
81. Kuznetsova NV, McBride DJ, Leikin S (2003) Changes in thermal stability and microunfolding pattern of collagen helix resulting from the loss of alpha2(I) chain in osteogenesis imperfecta murine. J Mol Biol. 331:191-200.
82. Kuznetsova NV, Forlino A, Cabral WA, Marini JC, Leikin S (2004) Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteo-genesis Imperfecta model. Matrix Biol. 23:101-112.
83. Lehmann HW, Mundlos S, Winterpacht A, Brenner RE, Zabel B, Muller PK (1994) Ehlers-Danlos syndrome type VII: phenotype and genotype. Arch Dermatol Res. 286:425-428.
84. Lethias C, Carisey A, Comte J, Cluzel C, Exposito JY (2006) A model of tenascin-X integration within the collagenous network. FEBS Lett. 580:6281-6285.
85. Lohler J, Timpl R, Jaenisch R (1984) Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell. 38:597-607.
86. Lopez Franco GE, Huang A, Pleshko Camacho N, Blank RD (2005) Dental phenotype of the col1a2(oim) mutation: DI is present in both homozygotes and heterozygotes. Bone. 36: 1039-1046.
87. Lopez Franco GE, Huang A, Pleshko Camacho N, Stone DS, Blank RD (2006). Increased Young's modulus and hardness of Col1a2 oim dentin. J Dent Res. 85:1032-1036.
88. Makareeva E, Cabral WA, Marini JC, Leikin S (2006) Molecular mechanism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syndrome: unfolding of an N-anchor domain at the N-terminal end of the type I collagen triple helix. J Biol Chem. 281:6463-6470.
89. Malfait F, De Paepe A (2005) Molecular genetics in classic Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 139:17-23.
90. Malfait F, Symoens S, Coucke P, Nunes L, De Almeida S, De Paepe A (2006) Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems. J Med Genet. 43:e36.
91. Malfait F, Symoens S, De Backer J, Hermanns-Le T, Sakalihasan N, Lapiere CM, Coucke P, De Paepe A (2007) Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. Hum Mutat. 28:387-395.
92. Marini JC (2006) Osteogenesis Imperfecta. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. M. J. Favus. Washington, DC., American Society for Bone and Mineral Research:418-420.
93. Marini JC, Cabral WA, Barnes AM, Chang W (2007a) Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development. Cell Cycle. 6:1675-1681.
94. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Korkko J, Prockop DJ, De Paepe A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH (2007b). Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 28:209-221.
95. Masunaga T (2006) Epidermal basement membrane: its molecular organization and blistering disorders. Connect Tissue Res. 47:55-66.
96. Mayer SA, Rubin BS, Starman BJ, Byers PH (1996) Spontaneous multivessel cervical artery dissection in a patient with a substitution of alanine for glycine (G13A) in the alpha 1 (I) chain of type I collagen. Neurology. 47:552-556.
97. McBride Jr.D.J., Choe V, Shapiro JR, Brodsky B (1997) Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol. 270:275-284.
98. McCarthy EA, Raggio CL, Hossack MD, Miller EA, Jain S, Boskey AL, Camacho NP (2002) Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res. 52:660-670.
99. Miller E, Delos D, Baldini T, Wright TM, Camacho NP (2007) Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone. Calcif Tissue Int. 81:206-214.
100. Misof K, Landis WJ, Klaushofer K, Fratzl P (1997) Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest. 100:40-45.
101. Mizuno K, Hayashi T, Peyton DH, Bachinger HP (2004) The peptides acetyl-(Gly-3(S)Hyp-4(R)Hyp)10-NH2 and acetyl-(Gly-Pro-3(S)Hyp)10-NH2 do not form a collagen triple helix. J Biol Chem. 279:282-287.
102. Morello R., Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bächinger HP, Pace JM, Schwarze U, Byersn PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 127:291-304.
103. Morike M, Brenner RE, Bushart GB, Teller WM, Vetter U (1992) Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients. Biochem J. 286(Pt 1):73-77.
104. Mottes M, Sangalli A, Valli M, Gomez Lira M, Tenni R, Buttitta P, Pignatti PF, Cetta G (1992) Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine alpha 1(I) 901 substitution in a type-I collagen gene. Hum Genet. 89:480-484.
105. Mottes M, Gomez Lira MM, Valli M, Scarano G, Lonardo F, Forlino A, Cetta G, Pignatti PF (1993) Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. Hum Mutat. 2:196-204.
106. Muriel MP, Bonaventure J, Stanescu R, Maroteaux P, Guenet JL, Stanescu V (1991) Morphological and biochemical studies of a mouse mutant (fro/fro) with bone fragility. Bone. 12:241-248.
107. Myllyla R, Wang C, Heikkinen J, Juffer A, Lampela O, Risteli M, Ruotsalainen H, Salo A, Sipila L (2007) Expanding the lysyl hydroxylase toolbox: new insights into the localization and activities of lysyl hydroxylase 3 (LH3). J Cell Physiol. 212:323-329.
108. Nicholls AC, Oliver J, Renouf DV, McPheat J, Palan A, Pope FM (1991) Ehlers-Danlos syndrome type VII: a single base change that causes exon skipping in the type I collagen alpha 2(I) chain. Hum Genet. 87:193-198.
109. Nicholls AC, Oliver J, Renouf DV, Heath DA, Pope FM (1992) The molecular defect in a family with mild atypical osteogenesis imperfecta and extreme joint hypermobility: exon skipping caused by an 11-bp deletion from an intron in one COL1A2 allele. Hum Genet. 88:627-633.
110. Nicholls AC, Oliver J, McCarron S, Winter GB, Pope FM (1996) Splice site mutation causing deletion of exon 21 sequences from the pro alpha 2(I) chain of type I collagen in a patient with severe dentinogenesis imperfecta but very mild osteogenesis imperfecta. Hum Mutat. 7: 219-227.
111. Nicholls AC, Sher JL, Wright MJ, Oley C, Mueller RF, Pope FM (2000) Clinical phenotypes and molecular characterisation of three patients with Ehlers-Danlos syndrome type VII. J Med Genet. 37:E33.
112. Nicholls AC, Valler D, Wallis S, Pope FM (2001) Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro(alpha)2(I) chain and an EDS/OI clinical phenotype. J Med Genet. 38:132-136.
113. Niyibizi C, Smith P, Mi Z, Phillips CL, Robbins P (2001) Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo. J Cell Biochem. 83: 84-91.
114. Nuytinck L, Freund M, Lagae L, Pierard GE, Hermanns-Le T, De Paepe A (2000) Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am J Hum Genet. 66:1398-1402.
115. Otterbach B, Stoffel W (1995) Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease).Cell. 81:1053-1061.
116. Oyama M, Tatlock A, Fukuta S, Kavalkovich K, Nishimura K, Johnstone B, Robbins PD, Evans CH, Niyibizi C (1999) Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Ther. 6:321-329.
117. Paterson CR, Mole PA (1994) Bone density in osteogenesis imperfecta may well be normal [see comments]. Postgrad Med J. 70:104-107.
118. Peltonen L, Palotie A, Prockop DJ (1980) A defect in the structure of type I procollagen in a patient who had osteogenesis imperfecta: excess mannose in the COOH-terminal propeptide. Proc Natl Acad Sci USA. 77:6179-6183.
119. Pereira R, Khillan JS, Helminen HJ, Hume EL, Prockop DJ (1993) Transgenic mice expressing a partially deleted gene for type I procollagen (COL1A1). A breeding line with a pheno-type of spontaneous fractures and decreased bone collagen and mineral. J Clin Invest. 91: 709-716.
120. Pereira RF, Hume EL, Halford KW, Prockop DJ (1995) Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age-dependent phenotype of human osteogenesis imperfecta. J Bone Miner Res. 10:1837-1843.
121. Pfeiffer BJ, Franklin CL, Hsieh FH, Bank RA, Phillips CL (2005) Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta. Matrix Biol. 24:451-458.
122. Phillips CL, Shrago-Howe AW, Pinnell SR, Wenstrup RJ (1990) A substitution at a non-glycine position in the triple-helical domain of pro alpha 2(I) collagen chains present in an individual with a variant of the Marfan syndrome. J Clin Invest 86:1723-1728.
123. Phillips CL, Pfeiffer BJ, Luger AM, Franklin CL (2002) Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). Kidney Int. 62:383-391.
124. Pollitt R, McMahon R, Nunn J, Bamford R, Afifi A, Bishop N, Dalton A (2006) Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV. Hum Mutat. 27:716.
125. Pornprasertsuk S, Duarte WR, Mochida Y, Yamauchi M (2005) Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J Bone Miner Res. 20:81-87.
126. Primorac D, Rowe DW, Mottes M, Barisic I, Anticevic D, Mirandola S, Gomez Lira M, Kala-jzic I, Kusec V, Glorieux FH (2001) Osteogenesis imperfecta at the beginning of bone and joint decade. Croat Med J. 42:393-415.
127. Prockop DJ (1984) Osteogenesis imperfecta: phenotypic heterogeneity, protein suicide, short and long collagen. Am J Hum Genet. 36:499-505.
128. Raff ML, Craigen WJ, Smith LT, Keene DR, Byers PH (2000) Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type VII. Hum Genet. 106:19-28.
129. Ristevski S (2005) Making better transgenic models: conditional, temporal, and spatial approaches. Mol Biotechnol. 29:153-163.
130. Rowe DW, Shapiro JR, Poirier M, Schlesinger S (1985) Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta. J Clin Invest. 76:604-611.
131. Sarafova, AP, Choi H, Forlino A, Gajko A, Cabral WA, Tosi L, Reing CM, Marini JC (1998) Three novel type I collagen mutations in osteogenesis imperfecta type IV probands are associated with discrepancies between electrophoretic migration of osteoblast and fibroblast collagen. Hum Mutat. 11:395-403.
132. Sarathchandra P, Pope FM, Kayser MV, Ali SY (2000) A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype. J Pathol. 192:385-395.
133. Schnieke A, Harbers K, Jaenisch R (1983) Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene. Nature. 304:315-320.
134. Schwarz M, Harbers K, Kratochwil K (1990) Transcription of a mutant collagen I gene is a cell type and stage-specific marker for odontoblast and osteoblast differentiation. Development. 108:717-726.
135. Schwarze U, Hata R, McKusick VA, Shinkai H, Hoyme HE, Pyeritz RE, Byers PH (2004) Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet. 74:917-930.
136. Seidler DG, Faiyaz-Ul-Haque M, Hansen U, Yip GW, Zaidi SH, Teebi AS, Kiesel L, Gottte M (2006) Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7). J Mol Med. 84: 583-594.
137. Shapiro JR, Burn VE, Chipman SD, Velis KP, Bansal M (1989) Osteoporosis and familial idio-pathic scoliosis: association with an abnormal alpha 2(I) collagen. Connect Tissue Res. 21: 117-123.
138. Shapiro JR, Stover ML, Burn VE, McKinstry MB, Burshell AL, Chipman SD, Rowe DW (1992) An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen. J Clin Invest 89:567-573.
139. Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 16:101-116.
140. Sillence DO, Ritchie HE, Dibbayawan T, Eteson D, Brown K (1993). Fragilitas ossium (fro/fro) in the mouse: a model for a recessively inherited type of osteogenesis imperfecta. Am J Med Genet. 45:276-283.
141. Slayton RL, Deschenes SP, Willing MC (2000) Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains. Matrix Biol. 19:1-9.
142. Spotila LD, Constantinou CD, Sereda L, Ganguly A, Riggs BL, Prockop DJ (1991) Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. Proc Natl Acad Sci USA. 88:5423-5427.
143. Spotila LD, Colige A, Sereda L, Constantinou-Deltas CD, Whyte MP, Riggs BL, Shaker JL, Spector TD, Hume E, Olsen N, et al. (1994) Mutation analysis of coding sequences for type I procollagen in individuals with low bone density. J Bone Miner Res. 9:923-932.
144. Stacey A, Bateman J, Choi T, Mascara T, Cole W, Jaenisch R (1988) Perinatal lethal osteogene-sis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene. Nature. 332:131-136.
145. Stankovic KM, Kristiansen AG, Bizaki A, Lister M, Adams JC, McKenna MJ (2007) Studies of otic capsule morphology and gene expression in the Mov13 mouse-an animal model of type 1 osteogenesis imperfecta. Audiol Neurootol. 12:334-343.
146. Steinmann B, Tuderman L, Peltonen L, Martin GR, McKusick VA, Prockop DJ (1980) Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem. 255:8887-8893.
147. Stoffel W, Jenke B, Block B, Zumbansen M, Koebke J (2005) Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc Natl Acad Sci USA. 102: 4554-4559.
148. Stoffel W, Jenke B, Holz B, Binczek E, Gunter RH, Knifka J, Koebke J, Niehoff A (2007) Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression. Am J Pathol. 171: 153-161.
149. Superti-Furga A, Pistone F, Romano C, Steinmann B (1989) Clinical
150. Suphapeetiporn K, Tongkobpetch S, Mahayosnond A, Shotelersuk V (2007) Expanding the phe-notypic spectrum of Caffey disease. Clin Genet. 71:280-284.
151. Sykes B, Francis MJ, Smith R (1977) Altered relation of two collagen types in osteogenesis imperfecta. N Engl J Med. 296:1200-1203.
152. Symoens S, Nuytinck L, Legius E, Malfait F, Coucke PJ, De Paepe A (2004) Met>Val substitution in a highly conserved region of the pro-alpha1(I) collagen C-propeptide domain causes alternative splicing and a mild EDS/OI phenotype. J Med Genet. 41:e96.
153. Tenni R, Biglino P, Dyne K, Rossi A, Filocamo M, Pendola F, Brunelli P, Buttitta P, Borrone C, Cetta G (1991) Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. J Inherit Metab Dis. 14:189-201.
154. Thorner PS (2007) Alport syndrome and thin basement membrane nephropathy. Nephron Clin Pract. 106:c82-c88.
155. Tkocz C, Kuhn K (1969) The formation of triple-helical collagen molecules from alpha-1 or alpha-2 polypeptide chains. Eur J Biochem. 7:454-462.
156. Van Camp G, Snoeckx RL, Hilgert N, van den Ende J, Fukuoka H, Wagatsuma M, Suzuki H, Smets RM, Vanhoenacker F, Declau F, Van de Heyning P, Usami S. (2006) A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene. Am J Hum Genet. 79:449-457.
157. Vasan NS, Kuivaniemi H, Vogel BE, Minor RR, Wootton JA, Tromp G, Weksberg R, Prockop DJ (1991) A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype. Am J Hum Genet 48:305-317.
158. Vranka JA, Sakai LY, Bachinger HP (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem. 279:23615-23621.
159. Wallis GA, Starman BJ, Zinn AB, Byers PH (1990) Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent. Am J Hum Genet. 46:1034-1040.
160. Walter K, Tansek M, Tobias ES, Ikegawa S, Coucke P, Hyland J, Mortier G, Iwaya T, Nishimura G, Superti-Furga A, Unger S (2007) COL2A1-related skeletal dysplasias with predominant meta-physeal involvement. Am J Med Genet A. 143:161-167.
161. Wang XM, Cui FZ, Ge J, Zhang Y, Ma C (2002) Variation of nanomechanical properties of bone by gene mutation in the zebrafish. Biomaterials. 23:4557-4563.
162. Wang XM, Cui FZ, Ge J, Wang Y (2004) Hierarchical structural comparisons of bones from wildtype and liliput (dtc232) gene-mutated Zebrafish. J Struct Biol. 14:236-245.
163. Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH (2002) Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone. 31:12-18.
164. Warman ML, Abbott M, Apte SS, Hefferon T, McIntosh I, Cohn DH, Hecht JT, Olsen BR, Fran-comano CA (1993) A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet. 5:79-82.
165. Watson RB, Wallis GA, Holmes DF, Viljoen D, Byers PH, Kadler KE (1992) Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section. J Biol Chem. 267:9093-9100.
166. Weil D, Bernard M, Combates N, Wirtz MK, Hollister DW, Steinmann B, Ramirez F (1988) Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant. J Biol Chem. 263:8561-8564.
167. Weil D, D'Alessio M, Ramirez F, de Wet W, Cole WG, Chan D, Bateman JF (1989a) A base substitution in the exon of a collagen gene causes alternative splicing and generates a structurally abnormal polypeptide in a patient with Ehlers-Danlos syndrome type VII. Embo J. 8: 1705-1710.
168. Weil D, D'Alessio M, Ramirez F, Steinmann B, Wirtz MK, Glanville RW, Hollister DW (1989b) Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII. J Biol Chem. 264:16804-16809.
169. Weil D, D'Alessio M, Ramirez F, Eyre DR (1990) Structural and functional characterization of a splicing mutation in the pro-alpha 2(I) collagen gene of an Ehlers-Danlos type VII patient. J Biol Chem. 265:16007-16011.
170. Wenstrup RJ, Florer JB, Davidson JM, Phillips CL, Pfeiffer BJ, Menezes DW, Chervoneva I, Birk DE (2006) Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J Biol Chem. 281:12888-12895.
171. Willing MC, Deschenes SP, Scott DA, Byers PH, Slayton RL, Pitts SH, Arikat H, Roberts EJ (1994) Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet. 55:638-647.
172. Willing MC, Pruchno CJ, Atkinson M, Byers PH (1992) Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet. 51:508-515.
173. Willing MC, Deschenes SP, Slayton RL, Roberts EJ (1996). Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet. 59:799-809.
174. Wirtz MK, Rao VH, Glanville RW, Labhard ME, Pretorius PJ, de Vries WN, de Wet WJ, Hollister DW (1993) A cysteine for glycine substitution at position 175 in an alpha 1 (I) chain of type I collagen produces a clinically heterogeneous form of osteogenesis imperfecta. Connect Tissue Res. 29:1-11.
175. Zhang Y, Cui FZ, Wang XM, Feng QL, Zhu XD (2002) Mechanical properties of skeletal bone in gene-mutated stopsel(dtl28d) and wild-type zebrafish (Danio rerio) measured by atomic force microscopy-based nanoindentation. Bone. 30:541-546.
176. Zhuang J, Tromp G, Kuivaniemi H, Castells S, Prockop DJ (1996) Substitution of arginine for glycine at position 154 of the alpha 1 chain of type I collagen in a variant of osteogene-sis imperfecta: comparison to previous cases with the same mutation. Am J Med Genet. 61: 111-116.
177. Zolezzi F, Valli M, Clementi M, Mammi I, Cetta G, Pignatti PF, Mottes M (1997) Mutation producing alternative splicing of exon 26 in the COL1A2 gene causes type IV osteogenesis imperfecta with intrafamilial clinical variability. Am J Med Genet. 71:366-370.
178. Zumbansen M, Stoffel W (2002) Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease. Mol Cell Biol. 22:3633-3638.